SCHEMBL7367333

SCHEMBL7367333

COc1cc(-c2cnc3cc(C)c(C)cc3n2)cc([N+](=O)[O-])c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
ALDH1A1 P00352 3/20 0.49
LMNA P02545 2/20 0.49
HTT P42858 1/20 0.49
PDGFRB P09619 3/20 0.46
PDGFRA P16234 2/20 0.46
CSNK2A2 P19784 1/20 0.45
CSNK2B P67870 1/20 0.45
CSNK2A1 P68400 1/20 0.45
GRK6 P43250 1/20 0.44
GAA P10253 4/20 0.43
GLA P06280 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 2/20 0.43
KDR P35968 1/20 0.43
FLT3 P36888 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7374010 0.86 MAPT (0.66) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL7371486 0.85 SMN1; SMN2 (0.47) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL7369499 0.72 MAPT (0.54) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL7366879 0.69 MAPT (0.63) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL11070819 0.69 GPR35 (0.69) MAPTSMN1; SMN2ALDH1A1LMNACSNK2A2
SCHEMBL15056522 0.69 NPC1 (0.62) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL30846536 0.68 NPC1 (0.73) MAPTSMN1; SMN2ALDH1A1PDGFRBNPC1
SCHEMBL29184271 0.68 NPC1 (0.73) MAPTSMN1; SMN2ALDH1A1PDGFRBNPC1
SCHEMBL23751958 0.68 TTR (0.61) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL9185312 0.68 POLB (0.46) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed